Search

Insulet Corp

Closed

SectorHealthcare

137.83 4.57

Overview

Share price change

24h

Current

Min

131.56

Max

132.88

Key metrics

By Trading Economics

Income

3.9M

95M

Sales

40M

802M

P/E

Sector Avg

27.618

56.597

EPS

1.66

Profit margin

11.85

Employees

5,400

EBITDA

-22M

132M

Dividends

By Acuity

Next Earnings

5 Nov 2026

Market Stats

By TradingEconomics

Market Cap

-1.5B

10B

Previous open

133.26

Previous close

137.83

News Sentiment

By Acuity

64%

36%

287 / 339 Healthcare

Insulet Corp Chart

Past performance is not a reliable indicator of future results.

Related News

10 Sept 2026, 20:07 UTC

News

Insulet Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, contributing to a decline in shares during Thursday's session.

9 Sept 2026, 23:16 UTC

Insulet Corp shares are higher in after-market hours, gaining since Wednesday's close. This follows a recent trend of four consecutive lower finishes.

8 Sept 2026, 20:07 UTC

News
Social Media

Insulet Corp shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, targeting potential claims of corporate wrongdoing.

4 Sept 2026, 20:07 UTC

Insulet Corp's shares are lower today, reaching a session low earlier. The stock remains above its 20-day moving average amid notable volatility.

3 Sept 2026, 22:46 UTC

Insulet Corp shares are lower in after-market hours, despite earlier gains. No specific news was identified to explain the price movement.

2 Sept 2026, 19:36 UTC

Insulet Corp shares are declining today, despite an earlier peak. Broader market concerns include heightened geopolitical tensions and potential supply disruptions.

1 Sept 2026, 23:36 UTC

Insulet Corp's shares are higher in after-market hours, following notable trading activity. The stock remains above its 20-day moving average despite negative market sentiment.

31 Aug 2026, 20:07 UTC

News

Insulet Corp reported 23.5% revenue growth for Q2 2026, though it lowered FY2026 guidance. Shares are gaining today amid broader market trends.

28 Aug 2026, 19:16 UTC

Insulet Corp's shares are higher today, reflecting positive market sentiment despite earlier intraday volatility. No specific news was identified to explain the movement.

27 Aug 2026, 19:26 UTC

News

Insulet Corp faces a class action lawsuit alleging securities fraud related to manufacturing defects, contributing to a decline in shares today.

26 Aug 2026, 19:16 UTC

Social Media

Insulet Corp shares are higher today, supported by over $226,000 in December $200 call options. Recent PCE data may also influence market sentiment.

25 Aug 2026, 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

24 Aug 2026, 19:56 UTC

News

Insulet Corp shares are lower amid negative sentiment from two class action lawsuits alleging securities fraud related to product safety concerns.

21 Aug 2026, 19:56 UTC

Insulet Corp shares are higher today, reflecting positive market momentum. Broader market gains, particularly in cryptocurrency, contribute to the stock's upward movement.

20 Aug 2026, 23:11 UTC

Insulet Corp shares are trading lower in after-market hours, continuing a decline that follows a reversal from earlier highs. No specific news was identified.

19 Aug 2026, 23:01 UTC

Insulet Corp shares are higher in after-market trading, continuing a trend of gains over the last three sessions without any specific news driving the movement.

18 Aug 2026, 20:03 UTC

Insulet Corp's shares are higher today, having previously peaked before pulling back. The stock has advanced since Monday's close, despite no specific news.

17 Aug 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14 Aug 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13 Aug 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

12 Aug 2026, 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

11 Aug 2026, 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

10 Aug 2026, 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

7 Aug 2026, 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6 Aug 2026, 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5 Aug 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 Aug 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 Aug 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 Jul 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 Jul 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

Peer Comparison

Price change

Insulet Corp Forecast

Rating Consensus

By TipRanks

Moderate Buy

20 ratings

11

Buy

9

Hold

0

Sell

Sentiment

By Acuity

287 / 339 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat